Welcome to the 2021 LUPUS CORA Meeting Program Scheduling
The meeting will officially run on Central European Summer Time (CEST), GMT +2
To convert the meeting times to your local time Click Here
No Topic Needed
- Thomas Dörner (Germany)
Session description:
SLE is a heterogeneous disease. From the clinician’s perspective, optimal outcomes are generally considered to be remission or low disease activity (LDA). However, there is often a disconnect between the goals of therapy from a physician and patient perspective, which results in poor patient satisfaction with treatment. In this session, expert faculty will review appropriate goals for SLE therapy, and highlight the need for patient-centred care and shared decision-making in order to fully appreciate their patients’ needs, set appropriate goals and achieve optimal outcomes with effective therapy.
SLE Management in the 21st Century: Putting the Patient Front and Center
This activity is supported by an educational grant from Lilly.
Welcome and Introductions Where are we now with lupus management?
- Thomas Dörner (Germany)
What do we mean when we talk about successful outcomes in SLE management?
- Ronald F. Van Vollenhoven (Netherlands)
Putting the patient front and center
- Marta Mosca (Italy)
Looking to the future: emerging therapies for SLE
- Thomas Dörner (Germany)
Q & A
- Thomas Dörner (Germany)
- Ronald F. Van Vollenhoven (Netherlands)
- Marta Mosca (Italy)